This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2023!
8-11 May 2023RAI in Amsterdam

Jan Schouten
Principal Scientist at Byondis

Profile

Dr. Jan Schouten is a Principal Scientist in Cell Line Development at Byondis B.V. in Nijmegen, the Netherlands. He leads a team of scientists and technicians that is involved in the generation of cell lines suitable for biopharmaceutical production, but also in the production of recombinant proteins for research purposes. Dr. Schouten obtained his Ph.D. in Molecular and Cellular Biology in 1999 at the University of Leiden, the Netherlands. He joined Synthon Biopharmaceuticals in 2010 after nine years at Crucell (now Janssen) in Leiden. Synthon Biopharmaceuticals was rebranded Byondis in April 2020. Dr. Schouten has a strong background in cell line development, recombinant protein expression and in discovery and engineering of antibodies.

Agenda Sessions

  • Approaches towards minimizing cell line development timelines

    11:15